Get the Stockscreener App
0.00
100.00%
-2.35
Augmedix Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Augmedix Inc is engaged in ambulatory/clinical/hospital segments of the U.S. patient care services market with products that address medical note documentation needs. The company's products cater to large and small healthcare organizations but can also be adopted by individual practitioners. The company products extract data from natural clinician-patient conversations and convert it in real time to medical notes, which are seamlessly transferred to the electronic health record (EHR). The company's revenues consist of service fees charged to its customers to subscribe to the company's remote medical documentation and clinical support products.
See More
Previous Close:
$2.35
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$116.16M
Revenue:
$44.86M
Net Income/Loss:
$-19.17M
P/E Ratio:
0.00
EPS:
-0.4516
Net Cash Flow:
$-18.55M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$4.8599
Augmedix Inc Stock (AUGX) Company Profile
Name
Augmedix Inc
Sector
Industry
Phone
561-989-2208
Address
111 SUTTER STREET, SUITE 1300, SAN FRANCISCO
Compare AUGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AUGX
Augmedix Inc
|
0.00 | 116.16M | 44.86M | -19.17M | -18.55M | -0.4516 |
|
VEEV
Veeva Systems Inc
|
233.38 | 37.89B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
74.61 | 12.89B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
58.75 | 10.97B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
61.85 | 9.74B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
111.97 | 9.70B | 1.15B | 96.70M | -161.99M | 1.09 |
Augmedix Inc Stock (AUGX) Latest News
VR for Medical Market Future Growth: Innovation, Demand, and Market Trends 2025-2032 | Siemens Healthineers - EIN News
10 Best AI Medical Scribes (January 2025) - Unite.AI
Augmedix Wins Vizient Contract for Ambient Ai Documentation Solutions - Marketscreener.com
Augmedix Awarded Vizient Contract for Ambient AI Documentation Solutions - HIT Consultant
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AUGX, G - GuruFocus.com
Best AR and VR Healthcare Stocks (January 2025) - Securities.io
Commure Adds Memora Health to Its Digital Health Portfolio - Healthcare Innovation
STOCKHOLDER ALERT: The M&A Class Action Firm Investigates the Merger and Looming Vote on September 27, 2024, of Augmedix, Inc.AUGX - The Eastern Progress Online
Augmedix Achieves Oracle Validation with Industry Healthcare Expertise for Delivering Proven, Repeatable Integration - Yahoo Finance
Virtual Reality in Healthcare Market Insights | 2024 To 2033 Key - openPR
Tenet to deploy Commure’s AI scribe at physician network - Healthcare Dive
Critical Survey: Alibaba Group (NYSE:BABA) vs. Augmedix (NASDAQ:AUGX) - Defense World
Commure To Partner with HCA Healthcare on Ambient AI Platform - The Manila Times
Google looks to spearhead AI adoption in the public sector - SiliconANGLE News
Renaissance Technologies LLC Lowers Position in Augmedix, Inc. (NASDAQ:AUGX) - Defense World
Critical Comparison: SCWorx (NASDAQ:WORX) and Augmedix (OTCMKTS:AUGX) - Defense World
Trium Capital LLP Makes New $2.78 Million Investment in Augmedix, Inc. (NASDAQ:AUGX) - MarketBeat
Commure completes acquisition of Augmedix - Medical Buyer
General Catalyst-backed Commure acquires AI documentation company - Modern Healthcare
Augmedix Acquisition Enhances Commure’s Healthcare Tech Portfolio - TipRanks
Augmedix completes merger with Commure - TipRanks
Commure Completes Merger with Augmedix - Benzinga
Commure Completes Merger with Augmedix - StockTitan
Augmedix Inc. Merger Perils: Operational Risks and Stock Value Instability Ahead - TipRanks
Augmedix, Inc. (NASDAQ:AUGX) Short Interest Down 18.9% in September - MarketBeat
Augmedix shareholders approve merger with Commure - Investing.com India
Augmedix shareholders approve merger with Commure By Investing.com - Investing.com Australia
Augmedix (OTCMKTS:AUGX) Stock Price Up 0.4% - Defense World
Augmedix (OTCMKTS:AUGX) Shares Up 0.4% - MarketBeat
Augmedix, Inc. (NASDAQ:AUGX) Short Interest Update - Defense World
Augmedix, Inc. (NASDAQ:AUGX) Sees Significant Decline in Short Interest - MarketBeat
Augmedix discloses additional merger details amid litigation By Investing.com - Investing.com Australia
Augmedix discloses additional merger details amid litigation - Investing.com India
Medical Speech Recognition Software Market Report, 2030 - Grand View Research
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VGR, CNOB, AUGX on Behalf of Shareholders - GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WISA, EVBN, AUGX on Behalf of Shareholders - The Malaysian Reserve
Finansavisen - Finansavisen
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates - GlobeNewswire
Augmedix Inc [AUGX] stock for 2,103 USD was sold by Chatterjee Saurav - Knox Daily
Recent Insider Activity Could Benefit Augmedix Inc (AUGX) - Knox Daily
Augmedix Inc: Rising -62.88% from 52-Week Low, Can the Stock Stay Afloat? - The InvestChronicle
Augmedix (OTCMKTS:AUGX) Trading Down 0.4% - MarketBeat
Short Interest in Augmedix, Inc. (NASDAQ:AUGX) Rises By 98.6% - MarketBeat
Augmedix (OTCMKTS:AUGX) Stock Price Down 0.4% - Defense World
Augmedix extends agreement with healthcare partners - Investing.com
Augmedix Inc (AUGX) Becoming More Attractive for Investors - Knox Daily
Augmedix (NASDAQ:AUGX) Stock Quotes, Forecast and News Summary - Benzinga
Augmedix, Inc. (NASDAQ:AUGX) Shares Acquired by Vanguard Group Inc. - Defense World
Augmedix Inc (AUGX)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex
Augmedix (OTCMKTS:AUGX) Releases Earnings Results, Misses Estimates By $0.04 EPS - Defense World
Augmedix Inc Stock (AUGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.99%
0.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):